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ABSTRACT
Hemorrhagic stroke remains a significant cause of morbidity and mortality worldwide. 
However, the role of surgical treatment for hemorrhagic stroke remains controversial. 
Previous studies had proposed surgery can prevent herniation, lowering intracranial 
pressure (ICP) and reducing mass effect and cellular toxicity. Outcome in previous studies 
are conflicting. Studies concerning outcomes of surgical management of hemorrhagic 
stroke in Indonesia are limited. This study aimed to compare the outcome of hemorrhagic 
stroke treatment between surgical evacuation and conservative management in Dr. Sardjito 
General Hospital, Yogyakarta, Indonesia. Retrospective cohort study was conducted. 
Eighty spontaneous intracerebral hemorrhagic (ICH) stroke patients involved in this study 
during January 2014 to August 2015. Of whom 36 (45%) male and 44 (55%) female. There 
were 45 and 35 patients underwent surgical treatment and conservative management, 
respectively. Surgical treatment group survival was 74%, whereas the survival in the 
conservative group was 26%. There was a statistically significant difference between 
surgery group and conservative group (p<0.001; CI 95% 2.24-15.69). Furthermore, there 
was association of GCS less than 8, high systolic BP, intraventricullar hemorrhage (IVH) 
and length of stay (LOS) with poor outcome. Analysis also showed surgical treatment, 
lower GCS score and hypertension associate with unfavorable Glascow outcome scale 
(GOS). In conclusion, patients with hemorrhagic stroke who are surgically indicated might 
have an advantage of hematoma evacuation and better outcome. 
ABSTRAK
Stroke perdarahan masih merupakan penyebab signifikan morbiditas dan mortalitas di 
seluruh dunia. Kaidah pembedahan terhadap kebanyakan pasien stroke perdarahan 
masih dianggap kontroversial. Teori rasional untuk evakuasi hematoma berpatokan pada 
konsep prevensi herniasi, menurunkan tekanan intrakranial, dan menurunkan dampak 
hematoma pada jaringan sekitarnya dengan mengurangi efek massa atau toksisitas 
seluler. Penelitian yang menganalisis hasil penanganan pasien stroke perdarahan 
di pusat pelayanan bedah saraf di Indonesia masih terbatas. Penelitian ini bertujuan 
untuk menganalisis hasil penanganan pasien stroke perdarahan yang menjalani terapi 
pembedahan atau konservatif di Rumah Sakit Umum Pusat (RSUP) Dr. Sardjito. Penelitian 
ini merupakan penelitian kohort retrospektif yang membandingkan hasil klinis pada pasien 
stroke perdarahan yang menjalani pembedahan dan tidak di RSUP Dr. Sardjito, yang 
merupakan pusat rujukan kasus stroke perdarahan di provinsi DI Yogyakarta dari bulan 
Januari 2014 sampai dengan Agustus 2015. Dilakukan analisis terhadap data pasien 
meliputi umur, jenis kelamin, Glascow outcome scale (GOS), penanganan dan hasil dari 
penanganan yang diberikan. Pengumpulan data dilakukan di Instalasi Catatan Medis RSUP 
Dr. Sardjito. Dari 45 pasien yang dilakukan operasi, 74% pasien selamat. Dari 35 pasien 
yang diindikasikan untuk dilakukan operasi, tetapi tidak menjalani operasi, 26% pasien 
selamat. Terdapat hubungan yang bermakna antara terapi bedah dengan hasil klinis (p 
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<0,001; CI 95%: 2,24-15,69). Terdapat hubungan antara nilai GCS kurang dari 8, tingginya 
tekanan darah sistolik, perdarahan intraventrikular dan lama perawatan terhadap keluaran 
yang lebih buruk. Terdapat hubungan juga antara terapi bedah, GCS rendah, dan tekanan 
darah sistolik terhadap nilai GOS yang lebih buruk. Dapat disimpulkan bahwa pasien 
dengan stroke hemoragik yang diindikasikan dengan pembedahan kemungkinanmemiliki 
keuntungan evakuasi hematoma dan hasil yang lebih baik.
Keywords: intracerebral hemorrhagic stroke – surgical treatment – conservative 
management – outcomes
INTRODUCTION
Stroke remains a leading cause of 
morbidity and mortality around the world. 
There are two types of stroke, i.e. ischemic 
(non-hemorrhagic) stroke and hemorrhagic 
stroke. Over 80% of stroke are non-
hemorrhagic type, hemorrhagic stroke only 
accounted 15-22% of all mortality caused by 
stroke.1 Regardless of the small percentage, 
the hemorrhagic stroke has higher mortality 
rate than ischemic stroke. The role of 
surgical evacuation for hemorrhagic stroke 
remains controversial. The rational theory 
for the evacuation of hematoma based on 
the concept of prevent herniation, lowering 
the intracranial pressure and prevent the 
pathophysiology of hematoma impact on the 
surrounding tissue by reducing the effects of 
cellular toxicity mass or blood products.2-4
In previous studies, the outcomes 
of stroke treatment are inconsistent. 
Randomized controlled trials comparing 
surgical treatment with conservative 
treatment showed no significant benefit. 
Two prospective randomized controlled 
trials, and three meta analysis to compare the 
outcomes between conservative treatment 
and surgical treatment of intracerebral 
hemorrhage (ICH) also showed similar 
results. Randomized trials to compare 
between surgery and conservative 
management did not demonstrate a clear 
benefit for surgical intervention. Moreover, 
the generalizability of the results of these 
trials can be questioned, because patients 
at risk for herniation were likely excluded 
and the largest and most recent studies had 
high rates of treatment group crossover from 
conservative management to surgery.2
Studies concerning the outcomes of 
surgical management of hemorrhagic stroke 
in Indonesia are limited. This study aimed 
to compare the outcomes of intracerebral 
hemorrhagic stroke treatment between 
surgical evacuation and conservative 
management in Dr. Sardjito Hospital, 
Yogyakarta, Indonesia.
MATERIALS AND METHODS
Subjects
This was a retrospective cohort 
study comparing of the clinical outcome 
of  intracerebral hemorrhagic stroke 
patients who underwent surgery and 
conservative treatment in the Department of 
Neurosurgery, Dr. Sardjito General Hospital, 
Yogyakarta, Indonesia, within the period of 
January 2014 to August 2015. Data were 
collected form patient’s medical record. 
Patient’s sociocemographic and clinical 
characteristics, the therapy, and follow 
up of their outcome were collected. After 
treatment, patient’s outcome (recover or 
death), length of stay and Glasgow outcome 
scale (GOS) were identified.
Patients included in the study were 
patients who diagnosed with spontaneous 
ICH. Patients with subarachnoid hemorrhage 
or traumatic ICH were excluded in this study. 
Patients who were surgically indicated but 
the family refused to do were considered as 
conservative management group.
Protocol 
To compare sociodemographic 
characteristics of ICH patients, the gender, 
age, area of residence were identified 
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(TABLE 1). Patients were divided by 
gender (male and female), age at the time of 
admission and area of residence (same area 
as the medical institution or other area). 
Clinical characteristics are factors 
related to medical treatment received by the 
patients; and included diagnosis, whether 
surgery was performed, initial blood 
pressure and Glasgow coma scale (GCS), 
and length of stay (LOS). Glasgow outcome 
scale (GOS) were examined after discharge 
from hospital when patients went to follow 
up to hospital. Nontraumatic intracerebral 
TABLE 1 Variable observed of ICH patients
Variable Measure
Independent Variable
Sociodemographic 
•	 Sex 0. Male 1. Female
•	 Age Patient’s age
•	 Area 0. Same 1. Other
Clinical characteristics
•	 Management 0. Surgery 1. Conservative 
•	 Length of stay Days stay in hospital 
•	 Diagnosis 0. IVH 1. other
•	 Hypertension 0. Yes 1. No
•	 Glasgow coma scale (GCS) 0. ≤ 8 1. > 8
Dependent Variable
•	 Outcome 0. Recover 1. Death
•	 Glasgow outcome scale (GOS) 0. Favorable 1. Unfavorable
hemorrhage (I61.0-I61.9) were classifiable 
under ICD-10 codes. Surgery was classified 
as “performed” in case in which there was 
a recorded day of a main operation that was 
performed clearly for treatment purposes and 
not for diagnostic or exploratory purposes or 
to treat complications (the organization for 
economic cooperation and development also 
classifies medical and surgical categories 
based on whether surgery is performed). The 
length of stay was calculated by counting 
the number of days that passed between 
admission and discharge days. 
SPPS for Windows version 24.
RESULTS
A total 83 patients were recruited 
between January 2014 to August 2015. 
Among 83 stroke patients, the majority had 
ICH (80 or 96%), followed by subarachnoid 
hemorrhage (SAH) (2 or 3%) and malignant 
neoplasm of cerebrum (1 or 1%). Only 
patients diagnosed with IHC were included, 
so total sample analysed was 80 patients. 
TABLE 2 shows the frequency of sample 
based on hospitalization period and TABLE 
3 summarizes all characteristics measured.
Statistical analysis
The t test and Chi-square test were 
performed for comparative analysis 
of ICH patient characteristics such as 
sociodemoraphics, clinical conditions and 
managements, depending on outcome 
of treatment as recover or death and 
GOS, divided into favorable (GR/MD) 
or unfavorable (SD/V/D) outcome. Log 
transformation was performed for the systolic 
BP and LOS, as the average and median 
values exhibited asymmetric distribution. 
The level of significant was set as p < 0.05. 
Statistical analysis was performed using 
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TABLE 2. Number of sample data based on hospitalization period
Period Frequency (%)
January-December 2014 45 54.2
January-August 2015 38 45.8
Total 83 100
TABLE 3.  Characteristics of patients
Variable N % CI 95% (%)
Sex
•	 Male 36 45 34.1-55.9
•	 Female 44 55 44.1- 65.9
Age (mean ± SD years) 59.4 ± 13.51 56.4-62.3
Province
•	 Yogyakarta 62 76 66.6-85.3
•	 Central Java 14 18 6.4-21.6
•	 East Java 2 3 -0.7- 6.7
•	 West Java 1 2 -1.1-5.1
•	 Unknown 1 1 -1.2-3.2
Therapy
•	 Surgery 45 56 45.1-66.8
•	 Conservative 35 44 33.1-54.8
Outcome
•	 Recover 46 58 47.1-68.8
•	 Death 34 42 31.2-52.8
Length of stay (mean ± SD days) 12.9 ± 9.87 10.7-15.0
Diagnosis
•	 ICH unspecified 46 58 47.1-68.8
•	 ICH intraventricular 19 24 14.6-33.4
•	 ICH hemisphere 9 11 4.1-17.9
•	 ICH multiple localized 4 5 0.2-9.8
•	 ICH cerebellum 2 2 -1.1-5.1
Glasgow Coma Scale
•	 ≤ 8 54 68 57.8-78.2
•	 >8 26 32 21.8-42.2
Blood pressure (mean ± SD mmHg)
•	 Systole 153.4 ± 11.88 150.8-156.0
•	 Diastole 87.6 ± 6.79 86.1-89.1
Hypertension (>140 mmHg)
•	 Yes 62 78 68.9-87.1
•	 No 18 22 12.9-31.1
Glasgow outcome scale (GOS)
•	 Favorable 32 40 29.3-50.7
•	 Unfavorable 48 60 46.3-70.7
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TABLE 4 shows in ICH patients, surgical 
treatment group had better outcome than 
conservative group (p <0.001). Compared 
with patients who survived, died patients 
showed higher initial systolic BP (p=0.009), 
poorer initial lower GCS (p<0.001),  shorter 
LOS (p<0.001) and had slighty different 
outcome whether diagnosis was ICH with 
IVH or other ICH (p =0.03). Similarly, when 
compared with favorable GOS scoring, 
surgical treatment had better recovery 
outcome than conservative treatment 
(p<0.001), lower GCS score (p<0.001) and 
higher initial systolic BP ( p =0.03). 
TABLE 4. Outcome of hemorrhagic stroke treatment between surgical evacuation and 
conservative management
Variable
Outcome GOS
Recover
(n=46)
Death
(n=36) p OR/MD  (CI 95%)
Favorable
(n=32)
Unfavorable 
(n=48) p OR/MD  (CI 9 5%)
Sex*
•	 Male 18 18
0.220 0.57 ( 0.23-1.40)
12 24
0.270 0.60 (0.24-1.49)
•	 Female 28 16 20 24
Age
(mean ± SD mmHg)** 57.67 ± 13.02 61.62 ± 14.02 0.190 -3.94 (-10.00-2.12) 58.00 ± 13.77 60.25 ± 13.41 0.470 -2.25 (-8.46- 3.96)
GCS*
•	 ≤ 8 20 34
<0.001 0.37 (0.26-0.52)
7 47
<0.001 0.006 (0.001-0.051)
•	 > 8 26 0 25 1
Systole 
(mean ± SD mmHg)** 15.43 ± 10.55 157.32 ± 12.56 0.009 -6.88 (-12.04- -1.73)
149.94 ± 
10.31 155.65 ± 12.41 0.034 -5.70 (-10,98 - -0.43)
Diagnosis*
•	 IVH 7 12
0.037 0.33 (0.11-0.96)
4 15
0.054 0.31 (0.09-1.06)
•	 Other 39 22 28 33
LOS
(mean ± SD days)** 17.24 ± 10.12 7.09 ± 5.68 <0.001 10.15 (6.31-13.99) 13.13 ± 4.29 12.79 ± 12.31 0.860 0.33 (-3.53-4.19)
Therapy*
•	 Surg 34 11
<0.001 5.92 (2.24-15.69)
26 19
<0.001 6.61 (2.29-19.08)
•	 Cons 12 23 6 29
*: X2 analysis; **: t-test analysis; GCS: glasgow coma scale; LOS: length of stay; Surg: surgery; Cons: conservative; SD: standard deviation; IVH: intraventricular 
hemorrhage; GOS: Glasgow outcome scale; OR: odds ratio; MD: mean difference
TABLE  5 shows whether surgery was 
done or not, GCS score less than 8 tend to 
got surgery than  GCS score more than 8 (p 
=0.002). There were no association between 
sex, age, systolic BP and LOS with treatment 
choices for patients. Moreover, there were no 
association between sex, age, GCS, systolic 
BP and LOS with wether diagnosis was ICH 
with or without IVH. 
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TABLE 5. Factors associated with therapy and diagnosis
Variable
Therapy Diagnosis
Surgery
(n=45)
Conservative
(n=35) p OR/MD  (CI 95%)
IVH
(n=19)
Other
(n=61) p OR/MD  (CI 9 5%)
Sex*
•	 Male 17 19
0.140 0.51 (0.21-1.25)
12 24
0.068 2.64 (0.91-7.66)
•	 Female 28 16 7 37
Age
(mean ± SD mmHg)** 60.82 ± 14.46 57.46 ± 12.13 0.272 3.36 (-2.56-9.28) 61.05 ± 12.96 58.82 ± 13.72 0.533 2.23 (-4.81-9.27)
GCS*
•	 ≤ 8 24 30
0.002 0.19 (0.06-0.58)
16 28
0.075 3.23 (0.85-12.30)
•	 > 8 21 5 3 23
Systole 
(mean ± SD mmHg)** 152.69 ± 12.35 154.23 ± 11.38 0.569 -1.54 (-0.68- 3.82) 148.95 ± 10.34 154.74 ± 12.07 0.063 -5.79 (-11.54- -0.40)
LOS
(mean ± SD days)** 14.44 ± 8.83 10.97 ± 10.87 0.119 3.47 (-0.91-7.86) 13.11 ± 11.41 12.87 ± 9.44 0.928 0.24 (-4.95-5.43)
*: X2 analysis; **: t-test analysis; GCS: glasgow coma scale; LOS: length of stay; SD: standard deviation; OR: odds ratio; MD: mean difference; IVH: intra-
ventricular hemorrhage.
DISCUSSION
In this study, we found a better 
outcome (reduce mortality and better 
GOS) in hemorrhagic stroke patients 
underwent surgery compared to those 
who were conservatively managed. For 
over 50 years, there have been clinical 
trials of surgical clot evacuation aimed at 
reducing the mass effect.5,6 Since the first 
clinical trial of surgical ICH evacuation5, 
there have been multiple small trials but 
the result was conflicting.6 To clarify this, 
large surgical trial (the Surgical Trial in 
Intercerebral Hemorrhage (STICH) trial, 
n=1033) have  been conducted, but failed to 
demonstrate any benefit of clot evacuation.7 
Sub-analysis of the STICH I trials results 
indicated that superficial hematoma (<1 cm 
from cortical surface) lobar hemorrhage 
might benefit from clot evacuation, perhaps 
because reducing surgical trauma than deep 
hemorrhage patients. Additional subgroup 
analysis suggested that the risk for a poor 
outcome was increased for patients who 
presented as comatose (GCS score ≤8).2 
The STICH II trial addressed the 
question of whether early surgery would 
be beneficial for conscious patients with 
superficial lobar hemorrhage of 10 to 100 
mm3 within 1 cm of the cortical surface and 
without IVH and who were admitted within 
48 hours of ictus. STICH II trial resulted 
again no evidence of significantly improved 
outcome compared to medical treatment.8 
However, recent report, American Heart 
Association/American Stroke Association 
(AHA/ASA) guideline for spontaneous ICH 
management 2015 has suggested a possible 
role for craniectomy in ameliorating increased 
ICP caused by ICH.2 The guideline suggest 
that surgery give benefit for preventing 
herniation, reducing ICP and decreasing the 
pathophysiological impact of the hematoma 
on surrounding tissue by decreasing mass 
effect or the cellular toxicity of blood 
products. Whether surgery has the benefit 
on ICH still controversial, other approaches 
currently being tested use minimally invasive 
surgery in combination with hematoma lysis 
methods. In the minimally invasive surgery 
plus rtPA for intercerebral hemorrhage 
evacuation (MISTIE) trial (NCT00224770), 
a minimally invasive approach is being 
used with t-PA to assist evacuation9 and 
this has recently been reported to reduce 
perihematomal edema.10
Several nonrandomized studies have 
suggested that patients with cerebellar 
hemorrhages >3 cm in diameter or 
patients in whom cerebellar hemorrhage 
is associated with brainstem compression 
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or hydrocephalus have better outcomes 
with surgical decompression.11-14 A recent 
meta-analysis has suggested that u-PA, an 
alternate thrombolytic, is superior to t-PA for 
IVH clot evacuation.15
To understand underlying causes and 
natural history of ICH, several studies have 
been conducted, as well as preclinical studies 
involving animal models. Spontaneous ICH 
(not related to trauma), most frequently 
occurs secondary to hypertension.7 This 
similar found in our study, which higher 
blood pressure associated with mortality 
and morbidity. However, ICH may also 
result from bleeding associated with 
amyloid angiopathy, tumors, hemorrhagic 
conversion of ischemic stroke, dural venous 
sinus thrombosis, vasculitis and vascular 
marformations.16,17  
This study showed that higher systolic 
BP associated significantly with morbidity 
and mortality, whereas sex and age did 
not. Seventy-eight percent patients had 
hypertension when diagnosed with ICH. 
Broderick et al.14 and Zazulia et al.18 reported 
that post – hematoma  enlargement causes 
a midline shift and accelerates neurological 
deterioration.  Mendelow et al.7 revealed 
that nontraumatic ICH most frequently 
occurs secondary to hypertension, with 
up to 70% of patients with ICH having 
history of hypertension. Ruiz-Sandoval 
et al.17 also reported that hypertension is 
significant contributory factor for ICH and 
associated with morbidity and mortality. 
AHA/ASA guidelines for the management 
of spontaneous ICH 2015 recommended for 
ICH patients presenting with systolic BP 
between 150 and 220 mmHg and without 
contraindication to acute BP treatment, acute 
lowering of SBP to 140 mHg is safe (Class I, 
Level of Evidence A).2 It is also mentioned 
in Neurosurgery National Guideline 
for Healthcare that SBP>180 mmHg or 
MAP>130 mmHg with or without increased 
ICP should give anti-hypertension drug  to 
lowering  SBP.19  This guideline was used 
in Neurosurgery Department, Dr. Sardjito 
General Hospital, Yogyakarta as its clinical 
standard work pathway.
STICH trial found that comatose (GCS 
score ≤8) patients had increased the risk for 
a poor outcome7. Patients tended to be in 
a coma (GCS score ≤8), did not normalize 
with medical management. Our observations 
are consistent with previous study mention 
above, which comatose patients had higher 
mortality and unfavorable outcome. 
Current recommendations for 
management of ICH with IVH or 
hydrocephalus are for ICP monitoring when 
GCS less than 8 and for ventricular drainage, 
if there is decreased level of consciousness. 
Moreover, AHA/ASA recommended patients 
with a GCS score of ≤8, those with clinical 
evidence of transtentorial herniation, or 
those with significant IVH or hydrocephalus 
might be considered for ICP monitoring and 
treatment. A CPP of 50 to 70 mm Hg may 
be reasonable to maintain depending on the 
status of cerebral autoregulation (Class IIb; 
Level of Evidence C).4 In clinical standard 
work pathway used in Dr. Sardjito General 
Hospital, neurological deficit, increased ICP, 
hydrocephalus >24 hours and brain stem 
compression are an indication for surgical 
evacuation. 
The location of an ICH is important 
in determining the outcome and potential 
treatment. Depending on location, bleeding 
from an ICH may extend into ventricular 
system. Such intraventricular hemorrhage 
occurs in ~40% of ICH patients and 
predictor of poor outcome. Hanley20 reported 
that spontaneous ICH with IVH is about 
42%-55% of cases. IVH is an independent 
predictor of worse outcomes with mortality 
rates of 29-78%, compared to 5-29% for 
ICH without IVH. This finding was lower 
in our study, whereas ICH with IVH was 
account for 24%. However, ICH with IVH 
was an independent factor associated with 
higher mortality. 
In this study, the LOS for all patients 
was 12.9 days. Patients who underwent 
surgery stayed for 1.5 days longer (1.3 
times, 14.4 days) than patients who did not 
(10.9 days). Although there was no different 
for LOS in surgery or conservative group, 
however, there was significant difference 
349
J Med Sci, Volume 50, No. 3, 2018 July: 342-350 
for LOS between died or recover group. 
Kim et al.4 reported who targeted 700,056 
cases based on system data from the Korean 
Hospital Discharge In-Depth Injury Survey, 
that average LOS being 28.9 days; patient 
underwent surgery stayed in the hospital 
on average 9.2 days more (1.4 times, 35.1 
days) than patient who did not (25.9 days). 
However, factors associated with shorter 
length of stay was not discused in this study. 
The limitation of this study was we could 
not find clear cause of death of hemorrhagic 
stroke patients, whether hemorrhagic stroke 
only or other comorbid disease that was 
diagnosed during hospitalization period.
CONCLUSION
In conclusion, patients with hemorrhagic 
stroke who were surgically indicated might 
have an advantage of hematoma evacuation. 
The further and more targeted study is needed 
by incorporating the factors and causes of 
deaths related to surgical treatment, so that 
we can obtain more detailed data.
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